FDA Removes Black Box Warning: What the New HRT Guidelines Mean for Women’s Health and Hormone Therapy Safety

[madman]

Dr. Rachel Rubin and Dr. Kelly Caspersen discuss with FDA Commissioner Dr. Marty Makary the significant impact of hormone replacement therapy (HRT) on women's health, particularly in the context of recent FDA changes to black box warnings. They explore the misconceptions surrounding HRT, the importance of education for both clinicians and patients, and the long-term health benefits of hormone therapy. The discussion emphasizes the need for accurate labeling, comprehensive care, and empowering women to make informed choices about their health.